logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
D

Dariusz M. Kowalski

Maria Sklodowska-Curie National Research Institute of Oncology

43H-index
333Paper Count
2.7WCitation Count
Published Papers 65
Publication Date
logo
Best Practices and Communication Strategies for Informing Oncology Patients About Treatment Discontinuation and Transition to Palliative Care—A Practical Guide for Oncologists
errCancers
IF4.4
err2026-03-03
err0
errOAAI
errAleksandra Piórek; Adam Płużański; Dariusz M. Kowalski; Maciej Krzakowski
errShare
errSave
Venous Thromboembolism Management and Anticoagulation Opportunities in Cancer Patients
errEuropean Cardiology Review
IF3.6
err2026-01-01
err0
errOAAI
errSzmit, Sebastian; Krzakowski, Maciej; Kowalski, Dariusz M.; Zaborowska-Szmit, Magdalena
errShare
errSave
Trastuzumab Deruxtecan in Patients with HER2-Overexpressing Non-Small Cell Lung Cancer: Results From Part 1 of the Open-label, Multicenter, Phase 1b DESTINY-Lung03 Trial
errJournal of Thoracic Oncology
IF20.8
err2025-12-23
err0
errOAAI
errDavid Planchard; Hye Ryun Kim; Thatthan Suksombooncharoen; Rubi Li; Diego Cortinovis; Ji-Youn Han; Jens Samol; Yotsawaj Runglodvatana; Kang-Yun Lee; Gee-Chen Chang; Chun-Hui Lee; Dariusz Kowalski; Stephanie P.L. Saw; Yiqing Huang; Gerrina Ruiter; Myung-Ju Ahn; Tsung-Ying Yang; Cheng-Ta Yang; Aumkhae Sookprasert; Erica C. Nakajima
errShare
errSave
Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib
errClinical Lung Cancer
IF3.3
err2025-12-20
err0
PREAI
errPascale Tomasini; Oscar Juan-Vidal; Raffaele Califano; Chien-Chung Lin; Pauline Hulo; Christophe Dooms; Jian Fang; Ana Blasco; Dariusz Kowalski; Jorge Salinas; Govind Babu; Tho Lye Mun; Alessandra Bearz; Veerle Surmont; Clarissa Baldotto; Richu Sharma; Oscar Arrieta; Katarzyna Stencel; Cynthia Card; Alona Zer
errShare
errSave
Clinicopathologic Characteristics, Treatment Outcomes, and Survival in Thymic Neuroendocrine Neoplasms (t-NEN): A 25-Year Single-Center Experience
errCancers 2025, Vol. 17, Page 3932
IF4.4
err2025-12-09
err0
errOAAI
errAleksandra Piórek; Adam Płużański; Dariusz M. Kowalski; Maciej Krzakowski
errShare
errSave
Radiation Recall Pneumonitis with Pneumocystis jirovecii Superinfection and Treatment Induced Hyponatremia in a Patient with Non-Small-Cell Lung Cancer
errDiseases 2025, Vol. 13, Page 357
IF3
err2025-11-04
err0
errOAAI
errAleksandra Piórek; Adam Płużański; Dariusz M. Kowalski; Maciej Krzakowski
errShare
errSave
Anticoagulant therapy in patients with cancer and thrombocytopenia
errJOURNAL OF THROMBOSIS AND THROMBOLYSIS
IF2.2
err2025-10-01
err1
errOAAI
errSzmit, Sebastian; Kepski, Jaroslaw; Lech-Maranda, Ewa; Kowalski, Dariusz M.; Krzakowski, Maciej; Zaborowska-Szmit, Magdalena
errShare
errSave
Outcomes and prognostic insights in primary tracheal cancer: a multicenter retrospective study
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2025-09-30
err0
PREAI
errPiorek, Aleksandra; Napieralska, Aleksandra; Teterycz, Pawel; Pluzanski, Adam; Knetki-Wroblewska, Magdalena; Winiarczyk, Kinga; Tabor, Sylwia; Kowalski, Dariusz M.; Krzakowski, Maciej
errShare
errSave
Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study
errJournal of Thoracic Oncology
IF20.8
err2025-07-22
err0
PREAI
errSolange Peters; Christian Schulz; Martin Reck; Kumar Prabhash; Dariusz Kowalski; Aleksandra Szczesna; Baohui Han; Achim Rittmeyer; Toby Talbot; David Vicente; Raffaele Califano; Diego Cortinovis; Anh Tuan Le; Dingzhi Huang; Geoffrey Liu; Federico Cappuzzo; Jessica Reyes Contreras; Ramon Palmero; Milena Perez Mak; Sanjay Popat; Youyou Hu; Stefanie Morris; Minu K. Srivastava; Monika Kaul; Vilma Graupner; Barbara Gitlitz; Siow Ming Lee
errShare
errSave
A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC
errJournal of Thoracic Oncology
IF20.8
err2025-06-12
err0
errOAAI
errMyung-Ju Ahn; Aaron Lisberg; Yasushi Goto; Jacob Sands; Min Hee Hong; Luis Paz-Ares; Elvire Pons-Tostivint; Maurice Pérol; Enriqueta Felip; Shunichi Sugawara; Hidetoshi Hayashi; Byoung Chul Cho; George Blumenschein; Elaine Shum; Jong-Seok Lee; Rebecca S. Heist; Robin Cornelissen; Wen-Cheng Chang; Dariusz Kowalski; Hong Zebger-Gong; Michael Chargualaf; Wen Gu; Lan Lan; Paul Howarth; Richard Joseph; Isamu Okamoto
errShare
errSave
Effectiveness of First-Line Treatment with Anaplastic Lymphoma Kinase and ROS1 Protoncogene Inhibitors in Non-Small Cell Lung Cancer Patients-Real-World Evidence of Two Polish Cancer Centers
errCANCERS
IF4.4
err2025-04-07
err0
errOAAI
errGil, Michal; Winiarczyk, Kinga; Krawczyk, Pawel; Wojas-Krawczyk, Kamila; Lomza-Laba, Aleksandra; Obara, Adrian; Gajek, Lukasz; Reszka, Katarzyna; Tysarowski, Andrzej; Buczkowski, Jaroslaw; Chmielewska, Izabela; Jankowski, Tomasz; Szuba-Gil, Magdalena; Strzemski, Maciej; Kowalski, Dariusz M.; Milanowski, Janusz; Krzakowski, Maciej
errShare
errSave
The Phase 3 KEYLYNK-006 Study of Pembrolizumab Plus Olaparib Versus Pembrolizumab Plus Pemetrexed as Maintenance Therapy for Metastatic Nonsquamous NSCLC
errJOURNAL OF THORACIC ONCOLOGY
IF20.8
err2025-02-01
err3
PREAI
errGray, Jhanelle E.; Schenker, Michael; Sendur, Mehmet Ali Nahit; Leonova, Viktoriya; Kowalski, Dariusz; Kato, Terufumi; Orlova, Rashida; Yang, James Chih-Hsin; Langleben, Adrian; Pilz, Arnold; Ungureanu, Andrei; Mak, Milena Perez; De Angelis, Flavia; Aggarwal, Himani; Zimmer, Zachary; Zhao, Bin; Shamoun, Mark; Kim, Tae Min
errShare
errSave
Whole exome sequencing (WES) analyses from IMpower133 and 6-year (y) overall survival (OS) from IMbrella A in patients (pts) with extensive-stage small cell lung cancer (ESSCLC) treated with atezolizumab (atezo)
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err1
PREAI
errKao, S. C-H.; Reck, M.; Liu, S. V.; Dziadziuszko, R.; Hochmair, M. J.; Huemer, F.; Gilberto de Castro, J.; Bernabe Caro, R.; Kim, S. H.; Kowalski, D. M.; Andric, Z. G.; Oancea, M.; Kaul, M.; Li, H.; Danner, B.; Lee, M. C.; Nabet, B. Y.; Sugawara, S.
errShare
errSave
Venous thromboembolism is associated with increased all-cause mortality in ALK-positive non-small cell lung cancer
errCARDIO-ONCOLOGY
IF3.2
err2024-11-09
err0
errOAAI
errZaborowska-Szmit, Magdalena; Szmit, Sebastian; Olszyna-Serementa, Marta; Zajda, Katarzyna; Janowicz-Zebrowska, Anna; Jaskiewicz, Piotr; Kowalski, Dariusz M.; Krzakowski, Maciej
errShare
errSave
Tracheal Tumors: Clinical Practice Guidelines for Palliative Treatment and Follow-Up
errONCOLOGY REVIEWS
IF5.2
err2024-09-18
err1
errOAAI
errPiorek, Aleksandra; Pluzanski, Adam; Knetki-Wroblewska, Magdalena; Winiarczyk, Kinga; Tabor, Sylwia; Kowalski, Dariusz M.; Krzakowski, Maciej
errShare
errSave
Treatment outcomes of patients with primary tracheal tumors - analysis of a large retrospective series
errBMC CANCER
IF3.4
err2024-06-05
err1
errOAAI
errPiorek, Aleksandra; Pluzanski, Adam; Knetki-Wroblewska, Magdalena; Winiarczyk, Kinga; Tabor, Sylwia; Teterycz, Pawel; Kowalski, Dariusz M.; Krzakowski, Maciej
errShare
errSave
The combination of osimertinib and savolitinib as molecular inhibition of EGFR and MET receptors may be selected to provide maximum effectiveness and acceptable toxicity
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2024-06-01
err2
errOAAI
errKowalski, Dariusz M.; Zaborowska-Szmit, Magdalena; Szmit, Sebastian; Krzakowski, Maciej; Jaskiewicz, Piotr
errShare
errSave
Results from KEYNOTE-B99: Phase 2 study of first-line (1L) pembrolizumab (pembro) plus investigational agents and chemotherapy (chemo) for extensive-stage small-cell lung cancer (ES-SCLC)
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errRodriguez-Abreu, Delvys; Hochmair, Maximillian; Cho, Byoung Chul; Csoszi, Tibor; Kutiel, Talia Shentzer; Mueller, Veronika; Ahn, Myung-Ju; Kowalski, Dariusz; Maio, Michele; Moiseyenko, Vladimir; Navarro, Alejandro; Niu, Jianxin; Fung, Andrea S.; Lips, Carolin; Zhou, Heng; Zhao, Bin; Lara-Guerra, Humberto; Peled, Nir
errShare
errSave
Results from KEYMAKER-U01 substudy 3: a phase 2 umbrella study of pembrolizumab plus investigational agents in patients with non-small-cell lung cancer (NSCLC) previously treated with anti-PD-(L)1 therapy
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errAggarwal, Charu; Stevenson, James; Kowalski, Dariusz M.; Csoszi, Tibor; Peled, Nir; Cho, Byoung Chul; Rubio-Viqueira, Belen; Niu, Jiaxin; Carbone, David P.; Arnold, Susanne M.; Awad, Mark M.; Gainor, Justin F.; Rao, Suman; Tsao, Anne S.; Zhou, Heng; Akala, Omobolaji O.; Chartash, Elliot; Nadal, Ernest
errShare
errSave
Results from KEYNOTE-B98: A phase 1b/2 study of pembrolizumab plus investigational agents in patients with anti-PD-(L)1-refractory extensive-stage small-cell lung cancer (ES-SCLC)
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errNavarro, Alejandro; Ahn, Myung-Ju; Stevenson, James; Peled, Nir; Kutiel, Talia Shentzer; Huemer, Florian; Kim, Dong-Wan; Casulleras, Maria Jove; Khattak, Adnan; Kowalski, Dariusz; Leighl, Natasha B.; de Marinis, Filippo; Lips, Carolin; Niu, Jiaxin; Huang, Mo; Zhao, Bin; El-Osta, Hazem; Owonikoko, Taofeek
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
P
Pasi A. Jänne
H-index: 163 · Papers: 2.3K
J
James Chih‐Hsin Yang
H-index: 141 · Papers: 1.2K
Y
Yi‐Long Wu
H-index: 135 · Papers: 2.2K
R
Roy S. Herbst
H-index: 134 · Papers: 1.3K
T
Tony Mok
H-index: 131 · Papers: 1.1K
View more